High-yield points
- Indication: obstructive hydrocephalus . Shunt and ETV are equivalent guideline options (Level II) .
- ETVSS: age, etiology and prior shunt predict 6-month success . It still performs well in modern HCRN data (76% success at 6 months) .
- Timing of failure: ETV fails early, mostly within 3 months, and then has a lower failure risk than shunting . With ETVSS ≥80 it is favored almost immediately .
- Aqueductal stenosis: about 90% long-term success .
- Post-posterior fossa tumor hydrocephalus: success similar to shunting, with earlier failures and none after 3 years .
- Secondary ETV at shunt malfunction: about 63% success at 6 months .
- Anatomy: perforate between the mammillary bodies and infundibular recess, or guided by the dorsum sellae and clival line . The basilar artery lies beneath the floor, sometimes with a Liliequist membrane .
- Complications: 8.5% overall, permanent 2.4%, mortality 0.21%, basilar rupture 0.21% . Watch for hyponatremia in children ≤2 years .
- Late rapid deterioration: rare but lethal. Counsel families and consider a ventricular access device .
Landmark papers
- ETV Success Score (Kulkarni et al., J Pediatr 2009): derived from 618 ETVs at 12 international centers. It predicts 6-month success from age, etiology and prior shunt (C statistic 0.70; 67% success in the derivation set) .
- CNS/AANS pediatric hydrocephalus guideline (Limbrick et al., J Neurosurg Pediatr 2014): considers shunting and ETV equivalent options for pediatric hydrocephalus (Level II) .
- International Infant Hydrocephalus Study (Kulkarni et al., Childs Nerv Syst 2018): in infants with aqueductal stenosis, 5-year health status and quality of life were high and did not differ between ETV and shunt .
This topic covers ETV alone. ETV combined with choroid plexus cauterization in infants is covered in its own topic, Efficacy of ETV-CPC in Infants.
Indications
ETV treats obstructive (non-communicating) hydrocephalus by opening the floor of the third ventricle into the prepontine cistern . The CNS/AANS pediatric guideline considers shunting and ETV equivalent options for pediatric hydrocephalus (Level II) . The main factors in selection are the three components of the ETV Success Score (ETVSS): age, etiology and prior shunt . Typical settings are:
- Aqueductal stenosis: revision-free survival of about 90% at 5 years .
- Posterior fossa tumors:
- Before resection, how hydrocephalus was managed (EVD, ETV or resection alone) did not change the later need for CSF diversion in a 310-child multicenter study .
- For hydrocephalus that persists after resection, ETV and VP shunting had similar overall failure (31.0% vs 33.9%). ETV failed sooner (mean 0.45 vs 1.30 years), but no ETV failed after 3 years, while shunts kept failing beyond 5 years .
- Shunt malfunction (secondary ETV): pooled success was 66% at 3 months, 63% at 6 months and 53% at 12 months, with low complication rates .
- Infants with aqueductal stenosis: in the International Infant Hydrocephalus Study, 5-year health status and quality of life were high and did not differ between ETV and shunt .
Approach
A typical technique uses a frontal burr hole, a rigid endoscope, blunt perforation of the third ventricular floor, Fogarty balloon dilation and saline irrigation . Anatomy of the floor, from anterior to posterior:
- preoptic area, optic chiasm, tuber cinereum with the infundibulum, mammillary bodies, posterior perforated substance and midbrain tegmentum
- the basilar artery complex lies beneath the floor
- a Liliequist membrane, a condensation of arachnoid, is sometimes present below the floor
The floor itself can be thickened, thinned, effaced or herniated . The perforation is classically placed in the middle third of a line between the mammillary bodies and the infundibular recess. Using the dorsum sellae and clival line as the landmark has been proposed as a more consistent guide into the prepontine cistern . Pre- and postoperative MRI are central to planning and follow-up . Trajectory matters: in one series, a trajectory 10° or more from perpendicular was associated with postoperative hyponatremia, and so were age 2 years or younger and cystic loculations . Because late failure can be fatal, an indwelling ventricular access device is an option at the time of ETV .
Risks
In a systematic review of 2,985 ETVs :
- Overall: complications 8.5%, permanent morbidity 2.38%.
- Permanent neurological deficit 1.44%: hemiparesis, gaze palsy, memory disorders, altered consciousness.
- Permanent hormonal problems 0.94%: diabetes insipidus, weight gain, precocious puberty.
- Intraoperative: hemorrhage 3.7%, severe hemorrhage 0.6% (basilar rupture 0.21%), neural injury 0.24% (thalamus, fornix, hypothalamus, midbrain).
- Postoperative: CNS infection 1.81%, CSF leak 1.61%, intracranial hematoma 0.81%.
- Mortality: early mortality 0.21%, delayed sudden death 0.07%.
Results did not differ between pediatric and adult series . Hyponatremia occurred 1–8 days after ETV in 16% of one small series and can cause seizures . After posterior fossa tumor resection, ETV had more minor CSF leaks (10.3% vs 1.1%) and pseudomeningoceles (12.1% vs 3.3%) than shunting . The most feared late risk is rapid deterioration from a closed stoma. Sixteen cases were collected internationally, with failure 5 weeks to 7.8 years after ETV, and 13 children died. Patients and families should be counseled about this risk .
Likelihood of success
The ETVSS was derived from 618 ETVs at 12 international centers (see the ETV Success Score Calculator topic for the point values and an interactive calculator). It predicts 6-month success from age, etiology and prior shunt (C statistic 0.70; 67% success in the derivation set) . It closely predicts published series: predicted 57.9% vs actual 59.2%, explaining 62% of the variation between series . A 2024 HCRN re-evaluation of 761 first ETVs found 76% success at 6 months. The original ETVSS still predicted well, and a new score did not improve on it. Fronto-occipital horn ratio, third ventricle width and downward bowing of the third ventricular floor did not predict success. Prepontine adhesions on preoperative MRI showed a possible, non-significant association .
The ETV–shunt comparison changes over time. After adjusting for age and etiology, early failure was higher for ETV than for shunt, but after about 3 months ETV's failure risk became progressively lower . Good candidates (ETVSS ≥80) had lower failure risk than shunt soon after surgery. For ETVSS ≤70, ETV carried the higher risk at first and only crossed below shunt after 3–6 months .
Durability in good candidates is high. In aqueductal stenosis, revision-free survival was 91% at 6 months and 3 years and 89% at 5 years, and most failures occurred within 3 months . After a failed ETV in infants with aqueductal stenosis, a shunt did as well as a primary shunt, but repeat ETV failed in 3 of 4 .
Related topics
- Efficacy of ETV-CPC in Infants: the infant variant with cauterization.
- ETV Success Score Calculator: predicting 6-month success.
- Shunt Failure: secondary ETV at malfunction.
- Surgical Options in Shunting: the main alternative.
- Tumors of the Pineal Region: ETV for tumor-related hydrocephalus.
- Diffuse Midline Glioma, H3 K27-Altered: ETV with biopsy for midline tumors.
- Central Nervous System Tuberculosis: Neurosurgical Implications: ETV in tuberculous hydrocephalus.
- Intracranial and Spinal Parasitic Infections: Neurosurgical Implications: endoscopic neurocysticercosis cyst removal.
- Low-Grade Gliomas of the Brainstem in Children: tectal gliomas and ETV.
- Ventriculoperitoneal Shunt Insertion: the alternative to ETV.
- Surgical Approaches to the Pineal Region: step-by-step procedure.
References
- Limbrick DD Jr, Baird LC, Klimo P Jr, et al. Pediatric hydrocephalus: systematic literature review and evidence-based guidelines. Part 4: Cerebrospinal fluid shunt or endoscopic third ventriculostomy for the treatment of hydrocephalus in children. J Neurosurg Pediatr 2014;14 Suppl 1:30–34. doi:10.3171/2014.7.PEDS14324. PMID 25988780. verified
- Guil-Ibáñez JJ, Gomar-Alba M, Castelló-Ruiz MJ, et al. An overview of the use of the dorsum sellae and clival line as a guide in endoscopic third ventriculostomy: historical, anatomical and technical aspects. Neurosurg Rev 2025;48(1):283. doi:10.1007/s10143-025-03434-z. PMID 40044905. verified
- Kulkarni AV, Drake JM, Mallucci CL, et al. Endoscopic third ventriculostomy in the treatment of childhood hydrocephalus. J Pediatr 2009;155(2):254–259.e1. doi:10.1016/j.jpeds.2009.02.048. PMID 19446842. verified
- Henriksen KA, Kulamurugan A, Poon M, et al. Optimal management of hydrocephalus in children with posterior fossa tumors: an international retrospective multicenter study. J Neurosurg Pediatr 2025;35(5):460–466. doi:10.3171/2024.12.PEDS24424. PMID 40020235. verified
- Dewan MC, Isaacs AM, Cools MJ, et al. Treatment of hydrocephalus following posterior fossa tumor resection: a multicenter collaboration from the Hydrocephalus Clinical Research Network. J Neurooncol 2023;163(1):123–132. doi:10.1007/s11060-023-04316-4. PMID 37129738. verified
- Lee KS, Chari A, Gillespie CS, et al. Endoscopic third ventriculostomy for shunt malfunction in the pediatric population: a systematic review, meta-analysis, and meta-regression analysis. J Neurosurg Pediatr 2023;31(5):423–432. doi:10.3171/2023.1.PEDS22427. PMID 36787128. verified
- Kulkarni AV, Sgouros S, Leitner Y, et al. International Infant Hydrocephalus Study (IIHS): 5-year health outcome results of a prospective, multicenter comparison of endoscopic third ventriculostomy (ETV) and shunt for infant hydrocephalus. Childs Nerv Syst 2018;34(12):2391–2397. doi:10.1007/s00381-018-3896-5. PMID 29987375. verified
- Kulkarni AV, Sgouros S, Constantini S, et al. Outcome of treatment after failed endoscopic third ventriculostomy (ETV) in infants with aqueductal stenosis: results from the International Infant Hydrocephalus Study (IIHS). Childs Nerv Syst 2017;33(5):747–752. doi:10.1007/s00381-017-3382-5. PMID 28357554. verified
- Al-Khater KM. Surgical anatomy of the third ventricle floor: implications for endoscopic third ventriculostomy. World Neurosurg 2025;203:124493. doi:10.1016/j.wneu.2025.124493. PMID 40975308. verified
- Lang SS, Bauman JA, Aversano MW, et al. Hyponatremia following endoscopic third ventriculostomy: a report of 5 cases and analysis of risk factors. J Neurosurg Pediatr 2012;10(1):39–43. doi:10.3171/2012.4.PEDS1222. PMID 22702328. verified
- Drake J, Chumas P, Kestle J, et al. Late rapid deterioration after endoscopic third ventriculostomy: additional cases and review of the literature. J Neurosurg 2006;105(2 Suppl):118–126. doi:10.3171/ped.2006.105.2.118. PMID 16922073. verified
- Bouras T, Sgouros S. Complications of endoscopic third ventriculostomy. J Neurosurg Pediatr 2011;7(6):643–649. doi:10.3171/2011.4.PEDS10503. PMID 21631203. verified
- Kulkarni AV, Riva-Cambrin J, Browd SR. Use of the ETV Success Score to explain the variation in reported endoscopic third ventriculostomy success rates among published case series of childhood hydrocephalus. J Neurosurg Pediatr 2011;7(2):143–146. doi:10.3171/2010.11.PEDS10296. PMID 21284458. verified
- Kulkarni AV, Drake JM, Kestle JR, et al. Endoscopic third ventriculostomy vs cerebrospinal fluid shunt in the treatment of hydrocephalus in children: a propensity score-adjusted analysis. Neurosurgery 2010;67(3):588–593. doi:10.1227/01.NEU.0000373199.79462.21. PMID 20647973. verified
- Kulkarni AV, Drake JM, Kestle JR, et al. Predicting who will benefit from endoscopic third ventriculostomy compared with shunt insertion in childhood hydrocephalus using the ETV Success Score. J Neurosurg Pediatr 2010;6(4):310–315. doi:10.3171/2010.8.PEDS103. PMID 20887100. verified
- Verhey LH, et al. A re-evaluation of the Endoscopic Third Ventriculostomy Success Score: a Hydrocephalus Clinical Research Network study. J Neurosurg Pediatr 2024;33(5):417–427. doi:10.3171/2023.12.PEDS23401. PMID 38335514. verified
- García-Milán V, Moreno-Madueño G, Urreta Juárez G, et al. Long-term success of endoscopic third ventriculostomy in the pediatric population with aqueductal stenosis. World Neurosurg 2024;189:e364–e369. doi:10.1016/j.wneu.2024.06.056. PMID 38901481. verified
Verification (2026-10-23): each reference's authors, title, journal, volume, pages, DOI and PMID were checked on PubMed, and every figure cited was checked against the PubMed abstract. Full texts were not reviewed. The ETVSS point values are given, with their verification, in the ETV Success Score Calculator topic.